Basics Carisma Therapeutics, Inc. IPO Date: February 3, 2014 Sector: Healthcare Industry: Biotech Market Cap: $6.43M Activated in VL: True Average Daily Range Avg Daily Range: $0.11 | 5.02% Avg Daily Range (30 D): $0.01 | 14.37% Avg Daily Range (90 D): $0.02 | 9.06% Institutional Daily Volume Avg Daily Volume: 1.8M Avg Daily Volume (30 D): .38M Avg Daily Volume (90 D): 5.3M Trade Size Avg Trade Size (Sh.): 420 Avg Trade Size (Sh.) (30 D): 2,880 Avg Trade Size (Sh.) (90 D): 609 Institutional Trades Total Inst.Trades: 13 Avg Inst. Trade: $3.26M Avg Inst. Trade (30 D): $.8M Avg Inst. Trade (90 D): $.8M Avg Inst. Trade Volume: .6M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.58M Avg Closing Trade (30 D): $3.25M Avg Closing Trade (90 D): $3.25M Avg Closing Volume: 784.55K     News Jul 26, 2025 @ 5:47 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jul 16, 2025 @ 3:32 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Prnewswire Jul 15, 2025 @ 12:31 AM $HAREHOLDER ALERT: The M&A Class Action Firm Launc... Source: Juan Monteverde Jul 5, 2025 @ 1:48 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jul 1, 2025 @ 10:18 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Prnewswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $1.07 $-.23 $-.22 Diluted EPS $1.07 $-.23 $-.22 Revenue $ 45.3M $ M $ 3.7M Gross Profit $ $ $ Net Income / Loss $ 44.72M $ -9.77M $ -9.27M Operating Income / Loss $ 43.81M $ -5.78M $ -9.33M Cost of Revenue $ $ $ Net Cash Flow $ .78M $ -5.74M $ -10.17M PE Ratio 0.05     Splits Mar 08, 2023:   2:1